Bhutan vs Netherlands: Treatment success rate for patients treated for MDR-TB
Bhutan
91.0%
in 2022
Netherlands
91.0%
in 2021
Bhutan rank
21st
Netherlands rank
21st
Treatment success rate for patients treated for MDR-TB over time
- Bhutan
- Netherlands
How they compare
Bhutan currently reports 91.0% against 91.0% in Netherlands, a difference of 0.0%.
The two have swapped places 5 times across 15 shared years of data; in 2007 it was Netherlands ahead.
Bhutan ranks 21st and Netherlands ranks 21st of 163 countries.
Across the 3 decades both report, Bhutan averaged higher in 1 and Netherlands in 2.
Head to head by decade
| Decade | Bhutan | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.0% | 84.3% | 10.3% | Netherlands |
| 2010s | 92.1% | 77.0% | 15.1% | Bhutan |
| 2020s | 94.0% | 95.5% | 1.5% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Bhutan or Netherlands?
- Bhutan, at 91.0% against 91.0% in Netherlands as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Bhutan and Netherlands?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Netherlands?
- 15 years are reported by both, from 2007 to 2021.
- How do Bhutan and Netherlands rank globally for treatment success rate for patients treated for mdr-tb?
- Bhutan ranks 21st and Netherlands ranks 21st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.